Novel Use Of A-Sympathomimetics Having A 2-Imidazoline Structure

Patent No. EP1802302 (titled "Novel Use Of A-Sympathomimetics Having A 2-Imidazoline Structure") was filed by Merck Patent on Sep 16, 2005. The application was issued on Oct 26, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1802302

MERCK PATENT
Application Number
EP05784163A
Filing Date
Sep 16, 2005
Status
Granted And Under Opposition
Publication Date
Oct 26, 2016